Research progress in treatment strategies and prognostic factors for stage pT 2-3N 0M 0 thoracic esophageal squamous cell carcinoma

VernacularTitle:pT 2-3N 0M 0期胸段食管鳞状细胞癌治疗策略及预后影响因素研究进展
Author: Yang YU ¹ ; Shimin TANG ; Lu YANG ; Na LI
Author Information

1. 川北医学院临床医学系，南充　637000
Keywords: Esophageal squamous cell carcinoma; Antineoplastic protocols; Prognosis
From: Journal of International Oncology 2025;52(1):43-47
CountryChina
Language:Chinese
Abstract: Although patients with stage pT 2-3N 0M 0 thoracic esophageal squamous cell carcinoma are staged earlier, their postoperative local recurrence and distant metastasis rates are higher, resulting in a low five-year survival rate of such patients. The current neoadjuvant treatment for such patients is still in the research stage, and whether to give adjuvant radiotherapy and chemotherapy after surgery is still controversial. In addition, the prognostic factors of patients with pT 2-3N 0M 0 thoracic esophageal squamous cell carcinoma have not yet been clarified, and the causes of recurrence and metastasis are not yet clear. Therefore, it is of great significance to clarify treatment strategies and explore the impact of prognostic factors on improving the survival rate of such patients, which is expected to provide new directions for improving the prognosis and survival rate of patients with pT 2-3N 0M 0 thoracic esophageal squamous cell carcinoma.